Citations (18)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Andrew Vyse, Gillian Ellsbury & Harish Madhava. (2018) Protecting UK adolescents and adults against meningococcal serogroup B disease. Expert Review of Vaccines 17:3, pages 229-237.
Read now
Read now
Elena Gianchecchi, Alessandro Torelli, Giulia Piccini, Simona Piccirella & Emanuele Montomoli. (2015) Neisseria meningitidis infection: who, when and where?. Expert Review of Anti-infective Therapy 13:10, pages 1249-1263.
Read now
Read now
Articles from other publishers (16)
Emilija Sereikaitė, Rūta Plepytė, Aurelija Petrutienė, Dovilė Stravinskienė, Indrė Kučinskaitė-Kodzė, Vilmantas Gėgžna, Inga Ivaškevičienė, Aurelija Žvirblienė & Milda Plečkaitytė. (2023) Molecular characterization of invasive Neisseria meningitidis isolates collected in Lithuania (2009-2019) and estimation of serogroup B meningococcal vaccine 4CMenB and MenB-Fhbp coverage. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Crossref
David S. Stephens, Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2023. Plotkin's Vaccines. Plotkin's Vaccines
690
710.e7
.
Stefan Scholz, Magdalena Schwarz, Ekkehard Beck, Kinga Meszaros, Melanie Schneider, Bernhard Ultsch & Wolfgang Greiner. (2021) Public Health Impact and Cost-Effectiveness Analysis of Routine Infant 4CMenB Vaccination in Germany to Prevent Serogroup B Invasive Meningococcal Disease. Infectious Diseases and Therapy 11:1, pages 367-387.
Crossref
Crossref
Alessia Biolchi, Sara Tomei, Laura Santini, Rita La Gaetana, Elena Mori, Patricia Novy, Rino Rappuoli, Rafik Bekkat-Berkani, Marzia Monica Giuliani & Mariagrazia Pizza. (2020) Four-component Meningococcal Serogroup B Vaccine Induces Antibodies With Bactericidal Activity Against Diverse Outbreak Strains in Adolescents. Pediatric Infectious Disease Journal 40:2, pages e66-e71.
Crossref
Crossref
Ekkehard Beck, Johan Klint, Mohamed Neine, Stephanie Garcia & Kinga Meszaros. (2021) Cost-Effectiveness of 4CMenB Infant Vaccination in England: A Comprehensive Valuation Considering the Broad Impact of Serogroup B Invasive Meningococcal Disease. Value in Health 24:1, pages 91-104.
Crossref
Crossref
Mariagrazia Pizza, Rafik Bekkat-Berkani & Rino Rappuoli. (2020) Vaccines against Meningococcal Diseases. Microorganisms 8:10, pages 1521.
Crossref
Crossref
Jaime Moreno, Zonia Alarcon, Eliana Parra, Carolina Duarte, Olga Sanabria, Diego Prada & Jean Marc Gabastou. (2020) Molecular characterization of Neisseria meningitidis isolates recovered from patients with invasive meningococcal disease in Colombia from 2013 to 2016. PLOS ONE 15:7, pages e0234475.
Crossref
Crossref
María Eugenia León, Aníbal Kawabata, Minako Nagai, Liliana Rojas, Gustavo Chamorro & Grupo del laboratorio VIMENE Paraguay. (2019)
Genotipos de
Neisseria meningitidis
aislados de pacientes con enfermedad meningocócica en Paraguay, 1996-2015
. Revista Panamericana de Salud Pública 43, pages 1-8.
Crossref
Crossref
Dan M. Granoff, Andrew J. Pollard & Lee H. Harrison. 2018. Plotkin's Vaccines. Plotkin's Vaccines
644
662.e6
.
Eduardo LujanKathleen Winter, Jillandra Rovaris, Qin Liu & Dan M Granoff. (2017) Serum Bactericidal Antibody Responses of Students Immunized With a Meningococcal Serogroup B Vaccine in Response to an Outbreak on a University Campus. Clinical Infectious Diseases 65:7, pages 1112-1119.
Crossref
Crossref
Eve Dubé, Dominique Gagnon, Manale Ouakki, Sylvie Belley, Hélène Gagné, Nicole Boulianne, Monique Landry & Julie A. Bettinger. (2016) Meningococcal B vaccine acceptability: Results of a longitudinal study in Quebec (Canada). Vaccine Reports 6, pages 29-35.
Crossref
Crossref
Stephen I. Pelton. (2016) The Global Evolution of Meningococcal Epidemiology Following the Introduction of Meningococcal Vaccines. Journal of Adolescent Health 59:2, pages S3-S11.
Crossref
Crossref
Carol J. Baker. (2016) Prevention of Meningococcal Infection in the United States: Current Recommendations and Future Considerations. Journal of Adolescent Health 59:2, pages S29-S37.
Crossref
Crossref
Hoan Jong Lee, Young June Choe, Young-Jin Hong, Kyung-Hyo Kim, Su Eun Park, Yun-Kyung Kim, Chi-Eun Oh, Hyunju Lee, Hyoyoung Song, Hans Bock, Daniela Casula, Chiranjiwi Bhusal & Ashwani Kumar Arora. (2016) Immunogenicity and safety of a multicomponent meningococcal serogroup B vaccine in healthy adolescents in Korea—A randomised trial. Vaccine 34:9, pages 1180-1186.
Crossref
Crossref
Philip S. Watson & David P.J. Turner. (2016) Clinical experience with the meningococcal B vaccine, Bexsero ® : Prospects for reducing the burden of meningococcal serogroup B disease. Vaccine 34:7, pages 875-880.
Crossref
Crossref
Raffaella Rossi, Peter T. Beernink, Serena Giuntini & Dan M. Granoff. (2015) Susceptibility of Meningococcal Strains Responsible for Two Serogroup B Outbreaks on U.S. University Campuses to Serum Bactericidal Activity Elicited by the MenB-4C Vaccine. Clinical and Vaccine Immunology 22:12, pages 1227-1234.
Crossref
Crossref